Advarra
Latest Posts by Advarra
New Industry Framework Targets Repetitive Clinical Trial Site Training
Site-Sponsor Consortium Releases Practical Recommendations and Tools to Reduce Duplication, Ease Site Burden, and Support...
Read More...
How Recursion Identified Hidden Patient Burden in Early-Phase Oncology Study Design
Discover how Recursion partnered with Advarra to bring operational evidence into protocol design, uncovering potential...
Read More...
5 Warning Signs Your Study Startup Workflow Needs Attention
Study startup depends on coordinated work across sponsors, contract research organizations (CROs), sites, review bodies,...
Read More...SIV Companion Paper: Reducing Redundant Site Training Through Competency-Based, Role-Based, and Reusable Training Models
Read More...
When Are Adaptive Designs Best Suited for Oncology Trials?
Adaptive study designs are best suited for oncology clinical trials when meaningful uncertainty exists and...
Read More...
Types of Audits in Clinical Trials
Clinical trial audits are independent quality assurance evaluations of trial activities, records, systems, facilities, and...
Read More...
Q&A with Advarra’s Senior Director of IRB Services Christy Frey
Christy Frey has spent nearly two decades helping research move forward—ethically, efficiently, and always with...
Read More...
Advarra Launches Site Identification Technology with Insights Directly from Sites
New capability pairs intelligence from Advarra’s robust IRB and site source-of-truth operational systems, giving sponsors...
Read More...
Frequently Asked Questions About Investigator-Initiated Trials (IITs)
Investigator-initiated trials (IITs) play a critical role in advancing clinical research by allowing investigators to...
Read More...
What Is ALCOA+? A Practical Guide for Clinical Research
Clinical research decisions are only as sound as the records supporting them, and that soundness...
Read More...